Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037315 (
sleep apnea
)
8,000
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bimaxillary osteotomy for obstructive
sleep apnoea
Objective To gain insight into postoperative results of bimaxillary osteotomy in patients with obstructive
sleep apnoea
(OSA). Design Retrospective patient series. Method All patients with OSA who had undergone a bimaxillary osteotomy in the Amphia Hospital in
Breda
in the Netherlands in the past 4 years were eligible for inclusion. The primary outcome measures were the apnoea-hypopnoea index (AHI), a decrease in symptoms and the success of the operation. Results In the past 4 years, 22 patients with OSA underwent a bimaxillary osteotomy in the Amphia Hospital in
Breda
. We further analysed data from 18 patients. All patients had a normal to moderately elevated BMI. 94.1% had a complete absence or a marked decline in symptoms postoperatively. In 23.5% the cure was complete (AHI < 5/h) and treatment was successful in 52.9% of the patients (> 50% reduction in AHI and AHI < 20/h). The average AHI decreased from 38/h preoperatively to 11/h postoperatively. Conclusion Bimaxillary osteotomy is currently often regarded as a final treatment option for patients with OSA. Even in these patients with a relatively complex condition the results of the operation are relatively good. For treatment providers it is important to recognise patients who might benefit from a bimaxillary osteotomy, such as patients with OSA and retrognathia.
...
PMID:[Bimaxillary osteotomy for obstructive sleep apnoea]. 3112 Feb 8